Curriculum vitae

 

• Dr. D. Julián Sevilla Navarro
  Colaborador clínico docente.
• Facultativo Especialista de Area Hematología y Hemoterapia
  Hospital Infantil Universitario Niño Jesús
  Menendez Pelayo 65. Madrid. 28009.
  Tlf: 915035900 / 915035938
  Fax: 915035902
  E-mail: jsevilla.hnjs@salud.madrid.org

Descargar CV

 

Líneas de investigación

• Trasplante hematopoyético. Obtención y manipulación de células progenitoras hematopoyéticas. Conocimiento y aplicaciones clínicas en Anemia de Fanconi.

Proyectos de investigación subvencionados

1. “Aplicaciones de la biología molecular al diagnóstico y tratamiento de enfermos con Anemia de Fanconi”. Redes temáticas de Investigación Cooperativa, expediente G03/089. 2003-2006.

2. “Aplicaciones de la biología molecular al diagnóstico y tratamiento de enfermos con Anemia de Fanconi”. Fondo de Investigaciones Sanitarias, expediente PI051822. Equipo investigador. 2006-2007.

3. “Application of Modern Biology in the Development of Improved Diagnostic Tools and More Efficient Therapies for Patients with Mutated Fanconi Anemia/BRCA Genes” (“Proyecto FANCOGENE”) Ref 03/08-02/10.

MEritos acadEmicos

- Doctor en Medicina por la Universidad Autónoma de Madrid al desarrollar la tesis: “Recolección de progenitores hematopoyéticos de sangre periférica en la población pediátrica. Efectos secundarios y seguridad del procedimiento. Factores que predicen la cosecha. Estudio del reclutamiento” (2003).

- Profesor Honorario Departamento de Pediatría: Curso académico 2006-2007.

- Colaborador clínico docente: Curso académico 2007-2008.

Cursos de doctorado dirigidos

- Actualización en Hematología pediátrica. Departamento de Pediatría. Universidad Autónoma de Madrid, Madrid Mayo de 2005. Curso académico 2004-2005 (3 créditos).

- Actualización en Hematología pediátrica. Departamento de Pediatría. Universidad Autónoma de Madrid, Madrid Mayo de 2006. Curso académico 2005-2006 (3 créditos).

- Actualización en Hematología pediátrica. Departamento de Pediatría. Universidad Autónoma de Madrid, Madrid Mayo de 2007. Curso académico 2006-2007 (3 créditos).

Publicaciones internacionales

1. M CANALES, J SEVILLA, E OJEDA, F HERNÁNDEZ NAVARRO. Successful treatment of Trichosporon beigelii pneumonia with itraconazole. Clinical Infectious Diseases, 1998; 26; 999-1000.

2. J SEVILLA, M.T. ALVAREZ, D. HERNÁNDEZ, M. CANALES, J.G. DE BUSTOS, M. MAGALLÓN, G. GARZÓN AND F. HERNÁNDEZ-NAVARRO. Therapeutic embolization and surgical excision of haemophilic pseudotumour. Haemophilia 1999 Sep;5(5):360-3.

3. J SEVILLA , D HERNÁNDEZ-MARAVER, MJ AGUADO, E OJEDA, M MORADO, F HERNÁNDEZ-NAVARRO. Autologous peripheral blood stem cell transplant in patients previously diagnosed with invasive aspergillosis. Annals of Hematology 2001; 80 (8), 456-459.

4. SEVILLA J, GONZALEZ-VICENT M, MADERO L, DÍAZ MA. Acute autoimmune hemolytic anemia following unrelated cord blood transplantation as an early manifestation of chronic graft-versus-host disease. Bone Marrow Transplantation. 2001 Jul; 28 (1): 89-92.

5. JULIÁN SEVILLA, MARTA GONZÁLEZ-VINCENT, LUIS MADERO, IMELDA GONZÁLEZ-MEDIERO, MIGUEL A. DÍAZ. Early onset of acute immune-mediated lung injury in a child undergoing allogeneic peripheral blood transplantation. American Journal of Hematology. 2002; 69: 56-58.

6. GONZALEZ-VICENT M, MADERO L, SEVILLA J, DIAZ MA. Clinical and economic evaluation of using granulocyte colony-stimulating factor after autologous peripheral blood progenitor cell transplantation in children. Haematologica. 2002 Jan;87(1):105-106.

7. SEVILLA J, RODRÍGUEZ A, HERNÁNDEZ-MARAVER D, DE BUSTOS G, AGUADO J, OJEDA E, ARRIETA R, HERNÁNDEZ-NAVARRO F. Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation. Annals of Hematology. 2002 Jan;81(1):11-5.

8. DIAZ MA, VICENT MG, PRUDENCIO M, RODRIGUEZ F, MARIN C, SERRANO A, SEVILLA J, CASADO J, MADERO L. “Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation”. Haematologica. 2002 Mar;87(3):292-8.

9. TORRELO A, SEVILLA J, MEDIERO IG, CANDELAS D, ZAMBRANO A. Malignant atrophic papulosis in an infant. British Journal Dermatology. 2002 May; 146 (5): 916-918.

10. SEVILLA J, GONZALEZ-VICENT M, MADERO L, DIAZ MA. Peripheral blood progenitor cell collection in low-weight children. Journal of Hematotherapy and Stem Cell Research 2002 Aug;11(4):633-42.

11. MADERO L, VICENT MG, SEVILLA J, PRUDENCIO M, RODRÍGUEZ F, DIAZ MA. Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplantation. 2002 Sep;30(6):355-358.

12. SEVILLA J, GONZALEZ-VICENT M, MADERO L, GARCIA SANCHEZ F, DIAZ MA. Granulocyte colony-stimulating factor alone at 12 gr/kg twice a day for 4 days for peripheral blood progenitor cell priming in pediatric patients. Bone Marrow Transplantation. 2002 Oct;30(7):417-420.

13. SEVILLA J, GONZALEZ-VICENT M, MADERO L, GARCIA SANCHEZ F, DIAZ MA. Large volume leukapheresis in small children: safety profile and variables affecting peripheral blood progenitor cell collection. Bone Marrow Transplantation. 2003 Feb;31(2):263-267.

14. GONZALEZ-VICENT M, DIAZ MA, SEVILLA J, MADERO L. Cerebral toxoplasmosis following etanercept treatment for idiophatic pneumonia syndrome after autologous peripheral blood progenitor cell transplantation (PBPCT). Annals of Hematology. 2003 Oct;82(10):649-53.

15. DIAZ MA, SEVILLA J, DE LA RUBIA J, VERDEGUER A, ESPIGADO I, VICENT MG, PASCUAL MJ, ZAMORA C, ARRIETA R, SERRANO D, DEL CANIZO C, ARBONA C, DE ARRIBA F, BARGAY J, BRUNET S, SANZ MA. Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation. Haematologica. 2003; 88: 919-22.

16. LASSALETTA A, PÉREZ A, DÍAZ MA, SEVILLA J, GONZÁLEZ-VICENT M, MADERO L. Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia. Journal of Pediatric Hematology Oncology. 2004; 26: 117-9.

17. SEVILLA J, GONZALEZ-VICENT M, FERNÁNDEZ-PLAZA S, MADERO L, DÍAZ MA. Heparin based anticoagulation during peripheral blood stem cell collection may increase the CD34+ cell yield. Haematologica. 2004; 89: 249-51.

18. AI BENITO, MA DIAZ, M GONZÁLEZ-VICENT, J SEVILLA AND L MADERO. Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplantation. 2004; 33: 675-690.

19. PEREZ-MARTINEZ A, QUINTERO V, VICENT MG, SEVILLA J, DIAZ MA, MADERO L. High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors. Journal of Neurooncology. 2004; 67:101-6.

20. ESCUDERO MC, LASSALETTA A, SEVILLA J, FERNANDEZ-PLAZA S, PEREZ A, DIAZ MA, MADERO L. Chemotherapy-related secondary acute myeloid leukemia in patients diagnosed with osteosarcoma. Journal of Pediatric Hematology Oncology. 2004; 26: 454-6.

21. FONCILLAS MA, DIAZ MA, SEVILLA J, VICENT MG, FERNANDEZ-PLAZA S, PEREZ A, MADERO L. Engraftment Syndrome Emerges as the Main Cause of Transplant-Related Mortality in Pediatric Patients Receiving Autologous Peripheral Blood Progenitor Cell Transplantation. Journal of Pediatric Hematology Oncology. 2004; 26: 492-496.

22. SEVILLA J, FERNANDEZ-PLAZA S, GONZALEZ-VICENT M, COLMENERO I, ECHEVARRIA JM, PEREZ A, DIAZ MA, MADERO L. Fatal hepatic failure secondary to acute herpes simplex virus infection. Journal of Pediatric Hematology Oncology. 2004; 2: 686-688.

23. GONZALEZ-VICENT M, MADERO L, SEVILLA J, RAMIREZ M, DIAZ MA. A prospective randomized study of clinical and economic consequences of using G-CSF following autologous peripheral blood progenitor cell (PBPC) transplantation in children.Bone Marrow Transplantation. 2004; 34: 1077-1081.

24. GONZALEZ-VICENT M, RAMIREZ M, SEVILLA J, PEREZ A, FERNANDEZ S, MADERO L, DIAZ MA. Engraftment syndrome after autologous peripheral blood progenitor cell transplantation in pediatric patients: a prospective evaluation of risk factors and outcome. Bone Marrow Transplantation. 2004; 34: 1051-1055.

25. SEVILLA J, DIAZ MA, FERNANDEZ-PLAZA S, GONZALEZ-VICENT M, MADERO L. Risks and methods for peripheral blood progenitor cell collection in small children. Transfusion and Apheresis Science. 2004; 31: 221-231.

26. SEVILLA J, DEL CARMEN ESCUDERO M, JIMENEZ R, GONZALEZ-VICENT M, MANZANARES J, GARCIA-NOVO D, MADERO L. Severe Systemic Autoimmune Disease Associated With Epstein-Barr Virus Infection. Journal of Pediatric Hematology Oncology. 2004; 26: 831-833.

27. PEREZ-MARTINEZ A, LASSALETTA A, GONZALEZ-VICENT M, SEVILLA J, DIAZ MA, MADERO L. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors. Journal of Neurooncology. 2005; 71: 33-8.

28. SEVILLA J, FERNÁNDEZ-PLAZA S, DIAZ MA, MADERO L. Hematopoietic transplantation for bone marrow failure syndromes and thalassemia. Bone Marrow Transplantation. 2005 Mar;35 Suppl 1:S17-21.

29. GONZÁLEZ-VICENT, MARTA; MARÍN, CATALINA; MADERO, LUIS; SEVILLA, JULIÁN; DÍAZ, MIGUEL ANGEL. Risk Score for Pediatric Intensive Care Unit Admission in Children Undergoing Hematopoietic Stem Cell Transplantation and Analysis of Predictive Factors for Survival. Journal of Pediatric Hematology Oncology. 2005; 27: 526-531.

30. JACOME A, NAVARRO S, CASADO JÁ, RIO P, MADERO L, ESTELLA J, SEVILLA J, BADELL I, ORTEGA JJ, OLIVE T, HANENBERG H, SEGOVIA JC, BUEREN JÁ. A simplified approach to improve the efficiency and safety of ex vivo hematopoietic gene therapy in fanconi anemia patients. Human Gene Therapy. 2006; 17: 245-50.

31. SEVILLA J, QUEROL S, MOLINES A, GONZALEZ-VICENT M, BALAS A, CARRIO A, ESTELLA J, ANGEL DIAZ M, MADERO L. Transient donor cell-derived myelodysplastic syndrome with monosomy 7 after unrelated cord blood transplantation. European Journal of Haematology. 2006; 77: 259-63.

32. CASADO JA, CALLEN E, JACOME A, RIO P, CASTELLA M, LOBITZ S, FERRO T, MUNOZ A, SEVILLA J, CANTALEJO A, CELA E, CERVERA J, SANCHEZ-CALERO J, BADELL I, ESTELLA J, DASI A, OLIVE T, ORTEGA JJ, RODRIGUEZ-VILLA A, TAPIA M, MOLINES A, MADERO L, SEGOVIA JC, NEVELLING K, KALB R, SCHINDLER D,HANENBERG H, SURRALLES J, BUEREN JA. SPANISH FANCONI ANEMIA RESEARCH NETWORK, SPAIN. A comprehensive strategy for the subtyping of Fanconi Anemia patients: conclusions from the Spanish Fanconi Anemia research network. Journal of Medical Genetics. 2007; 44: 241-9.

33. FERNANDEZ-PLAZA S, SEVILLA J, DIAZ MA, MADERO L, TAMARIZ-MARTEL A. Dyspnea as the first manifestation of primary pancreatic lymphoma. Pediatric Blood and Cancer. 2007; 50: 434.

34. SEVILLA J, PLAZA SF, GONZÁLEZ-VICENT M, LASSALETTA A, RAMÍREZ M, MADERO L, DÍAZ MA. PBSC collection in extremely low weight infants: a single-center experience. Cytotherapy. 2007; 9: 356-61.

35. SEVILLA J, DIAZ MA, MADERO L. Extramedullary acute lymphoblastic leukaemia in childhood. European Journal of Haematology. 2007; 79: 182.

36. PÉREZ A, GONZÁLEZ-VICENT M, RAMIREZ M, SEVILLA J, MADERO L, DÍAZ MA. Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients. British Journal of Haematology. 2008 Feb;140(3):340-3.

37. GONZÁLEZ-VICENT M, DÍAZ MA, COLMENERO I, SEVILLA J, MADERO L. Primary gastrointestinal aspergillosis after autologous peripheral blood progenitor cell transplantation: an unusual presentation of invasive aspergillosis. Transplant Infectious Disease. 2007 Dec 7 .

38. SEVILLA J, FERNÁNDEZ-PLAZA S, LASSALETTA A, GONZÁLEZ-VICENT M, CONTRA T, MADERO L. Early Acute Myeloblastic Leukemia Treatment for Childhood Myelodysplastic Syndrome With t(3;5) (NPM/MLF1). Journal of Pediatric Hematology Oncology. 2007; 29: 839-40.

Publicaciones nacionales

1. M.P. MARTÍN, R. ARRIETA, D. HERNÁNDEZ, J. SEVILLA, A. GARCÍA-GRANDE, F. HERNÁNDEZ-NAVARRO. Criopreservación de células CD34+. Sangre 1999 Mayo; 44, supl 1: 25-26.

2. M.A. CANALES, J SEVILLA, D. HERNÁNDEZ Y F. HERNÁNDEZ-NAVARRO.Eficacia del tratamiento combinado con inmunoglobulinas y plasmaféresis en una gestante con aloinmunización Rh y anticuerpos antifosfolípido. Medicina Clínica, Med Clin (Barc) 1999 Oct 9;113(11):438-9.

3. L. MADERO, J. SEVILLA. Transplante de progenitores hematopoyéticos en la adrenoleucodistrofia ligada al X. Rev Neurol. 2001; 33: 225-227.

4. L. MADERO, J. MOLINA, J. SEVILLA. Púrpura trombocitopénica idiopática: controversias. BCP Can Ped. 2001; 25 (2): 291-302

5. B. PANIZO, S. FERNÁNDEZ-PLAZA, C. SCAGLIONE, J. SEVILLA, M. GONZÁLEZ-VICENT Y L. MADERO. Infección por Listeria en leucemia linfoblástica aguda. Revista Española de Pediatría 2002; 58 (3): 220-222.

6. M. TORRABADELLA, JM DÍAZ, C ARBONA, JM SANCHO, J DE LA RUBIA, M CORRAL, P ORTIZ, J CID, J MUÑOZ, A GALMÉS, MP RODRÍGUEZ, JJ ORTEGA, J SEVILLA, C GÓMEZ, JM RIBERA, MA SANZ, MJ NIETO-GONZÁLEZ, J MACIÁ, L ESCODA, C FERRÁ Y FJ ZUAZU. Protocolos de movilización y aféresis para el TASPE. Estudio multicéntrico. Methods and Findings in Experimental and Clinical Pharmacology. 2003; 25: 9-13.

7. PÉREZ MARTÍNEZ, V. QUINTERO CALCAÑO, M. GONZÁLEZ VICENT, J. SEVILLA NAVARRO, M. A. DÍAZ PÉREZ, L. MADERO LÓPEZ. “Altas dosis de quimioterapia y soporte hematopoyético en el tratamiento de niños con meduloblastoma y tumor neuroectodérmico primitivo supratentorial de alto riesgo. Oncología 2004; 27 (2): 60-68.

8. M.C. AMIGO BELLO, J. SEVILLA NAVARRO, L., MADERO LÓPEZ. Trastornos de la coagulación en la edad pediátrica. Pediatría Integral 2004; VIII (5): 404-419.

9. S. FERNÁNDEZ-PLAZA, J. SEVILLA, L. MADERO. “Tratamiento del cáncer en pediatría: estado actual y expectativas futuras. Pediatría Integral 2004; VIII (6): 501-510.

10. A PÉREZ MARTÍNEZ, V QUINTERO CALCAÑO, M GONZÁLEZ VICENT, T CONTRA GÓMEZ, MA DÍAZ PÉREZ, L MADERO LÓPEZ, J SEVILLA NAVARRO. Trasplante autólogo con progenitores hematopoyéticos de sangre periférica en niños con tumores del sistema nervioso central de alto riesgo. Anales de Pediatría 2004; 61: 8-15.

11. S. FERNÁNDEZ-PLAZA, J. SEVILLA, T. CONTRA, N. MARTÍN, L. MADERO. Leucemia aguda en pacientes con síndrome de Down. Anales de Pediatría 2004; 61: 515-519.

12. J. SEVILLA, S. FERNÁNDEZ-PLAZA, Y L. MADERO. “Trasplante hematopoyético en las talasemias. Haematologica 2004; 89: S1: 181-184.

13. JULIÁN SEVILLA-NAVARRO, SANDRA FERNÁNDEZ-PLAZA Y LUIS MADERO-LÓPEZ. Seguridad del uso de la caspofungina en el tratamiento de pacientes pediátricos inmunodeprimidos. Enferm Infecc Microbiol Clin. 2005;(4)3:33-40.

14. S. FERNÁNDEZ-PLAZA, J. SEVILLA, L. MADERO. Factores de crecimiento hematopoyético. Revista Española de Pediatría 2006; 62 (6): 509-517.

15. BAYONA C, LASSALETTA A, PEREZ A, SEVILLA J, ALBI G, VILLA JR, MADERO L. Hemoptisis fatal secundaria a aspergilosis pulmonar invasiva en una paciente con leucemia mieloblástica aguda. An Pediatr. 2007; 67: 278-9.

CapItulos de libros

1. SEVILLA J, GONZALEZ-VICENT M, DIAZ MA, MADERO L. Peripheral Blood Progenitor Cell Collection in Small Children. Nova Publishers. Editor Greer, Erik V. 2005. ISBN: 1-59454-315-1

2. S. FERNÁNDEZ-PLAZA, J SEVILLA NAVARRO Y L MADERO LÓPEZ. Retinoblastoma. En: M. Lázaro Quintela, M.Jorge Fernández, J. Carrasco Alvarez, J. Castellanos Díez, editores. Guía practica de tumores poco frecuentes. Madrid, Ed. You&us. 2003; 195-202. ISBN: 84-96015-14-9.

3. LASSALETTA ATIENZA ALVARO; SEVILLA NAVARRO JULIÁN; TOMÁS MARTÍNEZ JOSÉ FRANCISCO Y MADERO LÓPEZ LUIS. Tratamiento de la leucemia aguda linfoblástica. En Terapia en Oncohematología. Ed. Elsevier. Tercera edición; 2005; 107-122. ISBN: 84-8174-813-7.

4. J. SEVILLA NAVARRO, S. FERNÁNDEZ PLAZA, L. MADERO LÓPEZ. Linfomas no Hodgkin infantiles. En: L. Madero López, A. Muñoz Villa, editores. Hematología y Oncología pediátricas. Madrid: Ergón ed; 2005. p 523-534. ISBN: 84-8473-367-X.

5. J. SEVILLA NAVARRO, S. FERNÁNDEZ PLAZA, L. MADERO LÓPEZ. Anemias hemolíticas I. Alteraciones de la membrana eritrocitaria. Anemias por defectos enzimáticos. Anemia hemolitica autoinmune. En: L. Madero López, A. Muñoz Villa, editores. Hematología y Oncología pediátricas. Madrid: Ergón ed; 2005. p 59-74. ISBN: 84-8473-367-X.

6. S. FERNÁNDEZ PLAZA, J. SEVILLA NAVARRO, L. MADERO LÓPEZ. Factores de crecimiento hematopoyético. En: L. Madero López, A. Muñoz Villa, editores. Hematología y Oncología pediátricas. Madrid: Ergón ed; 2005. p 443-450. ISBN: 84-8473-367-X.

7. S. FERNÁNDEZ PLAZA, J. SEVILLA NAVARRO, L. MADERO LÓPEZ. Terapia de soporte. En: L. Madero López, A. Muñoz Villa, editores. Hematología y Oncología pediátricas. Madrid: Ergón ed; 2005. p 451-468. ISBN: 84-8473-367-X.

8. S. FERNÁNDEZ PLAZA, J. SEVILLA NAVARRO, L. MADERO LÓPEZ. Alteraciones de la coagulación. En: L. Madero López. editor. Manual de Hematología Pediátrica. Madrid: Ergón ed; 2006. p 141-158. ISBN: 84-8473-368-8.

9. J SEVILLA, L MADERO. Linfomas Infantiles. En: M. Cruz. Tratado de Pediatría. Madrid: Ergón ed; 2006. p 1585-1591. ISBN: 84-8473-421-8.

10. JULIÁN SEVILLA NAVARRO. Aspergilosis invasiva. En: Luis Madero, editor. Infección fúngica invasiva en el niño. Madrid: Ergón ed; 2008. p 77-100. ISBN: 978-84-8473-585-4.

11. JULIÁN SEVILLA NAVARRO. Infección fúngica en niños con problemas onco-hematológicos. En: Luis Madero, editor. Infección fúngica invasiva en el niño. Madrid: Ergón ed; 2008. p 159-182. ISBN: 978-84-8473-585-4.

COMUNICACIONES A CONGRESOS INTERNACIONALES DE HEMATOLOGIA Y HEMOTERAPIA

XIVTH MEETING OF THE INTERNATIONAL SOCIETY OF HAEMATOLOGY. EUROPEAN AND AFRICAN DIVISION.
ESTOCOLMO. SUECIA. 30 DE AGOSTO- 4 DE SEPTIEMBRE DE 1997.

- Dissappearance Of Inhibitor To Factor VIII In Two Hemophiliacs With Advanced HIV Disease.

- Hepatitis C Virus Genotypes In A Cohort Of Spanish Haemophiliacs.

AMERICAN SOCIETY OF HEMATOLOGY. THIRTY-NINTH ANNUAL MEETING. DECEMBER 5-9, 1997. SAN DIEGO, CA. USA.
PUBLICADO EN BLOOD. JOURNAL OF THE AMERICAN SOCIETY OF HEMATOLOGY. VOL 90, SUPPLEMENT 1 (PART 2 OF 2) TO, NOVEMBER 15, 1997.

- Blood Bank Automatic System Evaluation.

- Plasmapheresis And Endovenous Immunoglobulins For The Treatment Of Repeated Early Pregnancy Wastage Associated With Anti-PP1Pk.

- Evaluation Of The Polyethylene Glycol Antiglobulin Test For Detection And Identification Of Red Blood Cell Antibodies.

24TH ANNUAL MEETING EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION AND 14TH MEETING OF THE NURSES GROUP. COURMAYEUR, ITALY, MARCH 22-26, 1998. PUBLISHED IN BONE MARROW TRANSPLANTATION Volume 21, Supplement 1, March 1998.

- Comparison Between Allogeneic Transplantation With Cryopreserved PBSC Versus Unmanipulated Bone Marrow: Results In A Single Centre.

- Inmune Recovery After Autologous Stem Cell Transplantation In Patients With Advanced Or Metastasic Breast Cancer.

- According With Diagnosis Could Be Established Risk Toxicity Groups In Autologous PBSC Transplantation?.

XXIII INTERNATIONAL CONGRESS OF THE WORLD FEDERATION OF HEMOPHILIA. THE HAGUE, THE NETHERLANDS, MAY 17-22, 1998. PUBLISHED IN HAEMPHILIA, THE OFFICIAL JOURNAL OF THE WORLD FEDERATION OF HEMOPHILIA; VOLUME 4, NUMBER 3, MAY 1998.

- Comunicación oral.
Therapeutic Embolization And Surgical Excision Of Hemophilic Pseudotumor.

- Thrombophaty Secondary To Indinavir Therapy In Haemophiliac Patients With HIV Infection.

ISH-EHA COMBINED HAEMATOLOGY CONGRESS, AMSTERDAM, THE NETHERLANDS, 4-8 JULY 1998. PUBLISHED IN BRITISH JOURNAL OF HAEMATOLOGY, THE OFFICIAL JOURNAL OF THE BRITISH SOCIETY FOR HAEMATOLOGY AND THE EUROPEAN HAEMATOLOGY ASSOCIATION PUBLISHED BY BLACKWELL SCIENCE; VOLUME 102, NUMBER 1, JULY I, 1998.

- Comparison Between Allogeneic Transplantation With Cryopreserved PBSC Versus Unmanipulated Bone Marrow: Results In A Single Centre.

- Filgastrim After Peripheral Blood Stem Cell Transplantation: A Prospective-Randomized Study.

- Evolution And Survival After Autologous Hematopoietic Transplantation With Stem Cells In Patients Diagnosed Of Chronic Myeloid Leukemia.

- According With Diagnosis Could Be Established Risk Toxicity Groups In Autologous PBSC Transplantation?.

- Immune Thrombocytopenic Purpura And Splenectomy: Experience In A Series Of 540 Patients

AMERICAN SOCIETY OF HEMATOLOGY. FORTIETH ANNUAL MEETING. DECEMBER 4-8, 1998. MIAMI BEACH, FL, USA.
PUBLICADO EN BLOOD. JOURNAL OF THE AMERICAN SOCIETY OF HEMATOLOGY. VOL 92, SUPPLEMENT 1 (PART 1 OF 2 and 2 OF 2) TO, NOVEMBER 15, 1998.

- Autologous Hematopoietic Transplantation After Stem Cells Mobilization With High-Dose Hydroxyurea And G-CSF In Patients Diagnosed Of Chronic Myeloid Leukemia.

- Serum Ferritin As Prognostic Factor Of Veno-Occlusive Hepatic Disease.

- A Randomized Study Of Filgrastim (G-CSF) After Autologous Peripheral Blood Transplantation.

- Factor XI Deficiency Associated With Von Willebrand Disease.

- Factors Influencing Mobilization And Engraftment Of Peripheral Blood Progenitor Cells In Patients With Breast Cancer.

FOURTH CONGRESS OF THE EUROPEAN HAEMATOLOGY ASSOCIATION. BARCELONA, SPAIN, JUNE 9-12, 1999. PUBLICADO EN HAEMATOLOGICA. VOL 84, EHA-4 Abstract book, June 1999.

- Salvage Chemotherapy With Mini-Beam For Relapsed Or Refractory Hodgkin´S Disease.

- Thrombotic Thrombocytopenic Purpura In Pregnancy: Two New Cases.

- Medical Treatment For Invasive Aspergillosis Avoids A Recurrent Infection In PBSC Transplantation.

- Pericardial Effusion And Tamponade In Acute Leukemia.

52nd ANNUAL MEETING OF THE AMERICAN ASSOCIATION OF BLOOD BANKS.
SAN FRANCISCO, CA. USA. 6-10 NOVIEMBRE 1999. PUBLICADO EN TRANSFUSION. THE JOURNAL OF THE AMERICAN ASSOCIATION OF BLOOD BANKS. VOL 39, SUPPLEMENT No. 10S, OCTUBER 1999.

- Plasmapheresis And Immunoglobulin Treatment For Anti- PP1Pk And Anti-K Immunization.

41st ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY.
NEW ORLEANS, LOUISIANA. USA. 3-7 DICIEMBRE 1999.
PUBLICADO EN BLOOD. JOURNAL OF THE AMERICAN SOCIETY OF HEMATOLOGY. VOL 94, SUPPLEMENT 1 (PART 1 OF 2 and 2 OF 2) NO 10, NOVEMBER 15, 1999.

- Long-Term Prophylaxis With Cyclosporin-A To Prevent Chronic Graf-Vs-Host Disease After Allogeneic PBSC Transplantation.

- Effects Of Methylene Blue-Treated Plasma On Coagulation Factors.

26TH ANNUAL MEETING EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION AND 16TH MEETING OF THE NURSES GROUP. INNSBRUCK, AUSTRIA, MARCH 5-8, 2000. PUBLICADO EN BONE MARROW TRANSPLANTATION, MARZO 2000, VOL 25, SUPLEMENTO 1.

- MDS After Autologous Transplantation With Non-Programmed Frozen PBSC.

- Autologous CD34 selected periheral blood stem cell transplantation in a young patient with severe systemic sclerosis.

7TH MEETING OF THE EUROPEAN HEMATOLOGY ASSOCIATION. FLORENCE. ITALY. JUNE 2002. PUBLICADO EN THE HEMATOLOGY JOURNAL 2002; 3: SUPPL 1 ABSTRACT.

- Treatment related mortality in 166 pediatric patients undergoing peripheral blood progenitor cell transplantation.

- Adverse events related to large volume leukapheresis in low weight children.

- Granulocyte colony-stimulating factor alone 12g/kg twice a day for peripheral blood progenitor cell priming in pediatric patients.

XXXIVTH ANNUAL SIOP CONGRESS. OPORTO. PORTUGAL. SEPTIEMBRE 2002. PUBLICADO EN MEDICAL JOURNAL OF PEDIATRIC ONCOLOGY.

- Variables affecting peripheral blood progenitor cell collection by large volume leukapheresis in small children.

- Acute leukemia in Down´s syndrome patients.

 

30TH ANNUAL MEETING EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION AND 20TH MEETING OF THE NURSES GROUP. BARCELONA, SPAIN, MARCH 28-31, 2004. PUBLICADO EN BONE MARROW TRANSPLANTATION, MARZO 2004, VOL 33, SUPLEMENTO 1.

- Integral management of Fanconi´s anaemia patients in Spain.